Beatrice Knudsen (Karen E Knudsen, Karen Knudsen)

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 10

Top Topics

Radical Prostatectomy

Health Promotion

Top Venues

Journal of the National Cancer Institute. Monographs

The EMBO journal

Science advances

This page only lists publications with an associated author ORCID identifier.

Publications

Christina M Annunziata, William L Dahut, Cheryl L Willman, Robert A Winn, Beatrice Knudsen
Reflections on the state of telehealth and cancer care research and future directions. Journal of the National Cancer Institute. Monographs 2024 (64) (2024)
Christina M Annunziata, William L Dahut, Cheryl L Willman, Robert A Winn, Beatrice Knudsen
Reflections on the state of telehealth and cancer care research and future directions. Journal of the National Cancer Institute. Monographs 2024 (64) (2024)
William L Dahut, Arif H Kamal, Lisa A Lacasse, Kathryn M Sanders, Beatrice Knudsen
A tripartite approach toward ending cancer as we know it, for everyone: An American Cancer Society perspective. Journal of surgical oncology 128 (6) (2023)
Sandra Santasusagna, Shijia Zhu, Vijayakumar Jawalagatti, Marc Carceles-Cordon, Adam Ertel, Saioa Garcia-Longarte, Won-Min Song, Naoto Fujiwara, Peiyao Li, Isabel Mendizabal, Daniel P Petrylak, William Kevin Kelly, E Premkumar Reddy, Liguo Wang, Matthew J Schiewer, Amaia Lujambio, Robert Jeffrey Karnes, Beatrice Knudsen, Carlos Cordon-Cardo, Haidong Dong, Zhenlin Huang, Arkaitz Carracedo, Yujin Hoshida, Veronica Rodriguez-Bravo, Josep Domingo-Domenech
Master transcription factor reprograming unleashes selective translation promoting castration resistance and immune evasion in lethal prostate cancer. Cancer discovery (2023)
Zachary Quinn, Benjamin E Leiby, Guru P Sonpavde, Atish D Choudhury, Christopher J Sweeney, David J Einstein, Russell Zelig Szmulewitz, A Oliver Sartor, Beatrice Knudsen, Eddy Shih-Hsin Yang, William Kevin Kelly
Phase I Study of Niraparib in Combination with Radium-223 for the Treatment of Metastatic Castrate Resistant Prostate Cancer. Clinical cancer research : an official journal of the American Association for Cancer Research (2022)
Timothy J Stanek, Victoria J Gennaro, Mason A Tracewell, Daniela Di Marcantonio, Kristen L Pauley, Sabrina Butt, Christopher McNair, Feng Wang, Andrew V Kossenkov, Beatrice Knudsen, Tauseef Butt, Stephen M Sykes, Steven B McMahon
The SAGA complex regulates early steps in transcription via its deubiquitylase module subunit USP22. The EMBO journal 40 (16) (2021)
Ayesha A Shafi, Chris M McNair, Jennifer J McCann, Mohammed Alshalalfa, Anton Shostak, Tesa M Severson, Yanyun Zhu, Andries M Bergman, Nicolas Gordon, Amy C Mandigo, Saswati N Chand, Peter Gallagher, Emanuela Dylgjeri, Talya S Laufer, Irina A Vasilevskaya, Matthew J Schiewer, Michael Brunner, Felix Y Feng, Wilbert Zwart, Beatrice Knudsen
The circadian cryptochrome, CRY1, is a pro-tumorigenic factor that rhythmically modulates DNA repair. Nature communications 12 (1) (2021)
Jennifer J McCann, Irina A Vasilevskaya, Christopher McNair, Peter Gallagher, Neermala Poudel Neupane, Renée de Leeuw, Ayesha A Shafi, Emanuela Dylgjeri, Amy C Mandigo, Matthew J Schiewer, Beatrice Knudsen
Mutant p53 elicits context-dependent pro-tumorigenic phenotypes. Oncogene (2021)
Matthew J Schiewer, Amy C Mandigo, Nicolas Gordon, Fangjin Huang, Sanchaika Gaur, Renée de Leeuw, Shuang G Zhao, Joseph Evans, Sumin Han, Theodore Parsons, Ruth Birbe, Peter McCue, Christopher McNair, Saswati N Chand, Ylenia Cendon-Florez, Peter Gallagher, Jennifer J McCann, Neermala Poudel Neupane, Ayesha A Shafi, Emanuela Dylgjeri, Lucas J Brand, Tapio Visakorpi, Ganesh V Raj, Costas D Lallas, Edouard J Trabulsi, Leonard G Gomella, Adam P Dicker, Wm Kevin Kelly, Benjamin E Leiby, Beatrice Knudsen, Felix Y Feng, Karen E Knudsen
PARP-1 regulates DNA repair factor availability. EMBO molecular medicine 10 (12) (2019)
Akihiro Yoshida, Yiwen Bu, Shuo Qie, John Wrangle, E Ramsay Camp, Edward S Hazard, Gary Hardiman, Renée de Leeuw, Beatrice Knudsen, J Alan Diehl
SLC36A1-mTORC1 signaling drives acquired resistance to CDK4/6 inhibitors. Science advances 5 (9) (2019)